TRA2: The dominant power of alternative splicing in tumors

The dysregulation of alternative splicing (AS) is frequently found in cancer and considered as key markers for cancer progression and therapy. Transformer 2 (TRA2), a nuclear RNA binding protein, consists of transformer 2 alpha homolog (TRA2A) and transformer 2 beta homolog (TRA2B), and plays a role...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jiancheng, Ma, Tie, Zhang, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161706/
https://www.ncbi.nlm.nih.gov/pubmed/37151663
http://dx.doi.org/10.1016/j.heliyon.2023.e15516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161706/
https://www.ncbi.nlm.nih.gov/pubmed/37151663
http://dx.doi.org/10.1016/j.heliyon.2023.e15516

Ejemplares similares